Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine + TACE in Unresectable HCC
NCT02013778Phase 2Terminated
- Sponsor
- Abramson Cancer Center
- Start
- Nov 2013
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxychloroquine in hepatocellular carcinoma (HCC), sponsored by Abramson Cancer Center. Started Nov 2013; status: terminated.
02
Drugs
hydroxychloroquine
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT02013778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02013778.